Genmab A/S (GMAB)
25.10
+0.30
(+1.23%)
USD |
NASDAQ |
Jun 09, 16:00
25.10
0.00 (0.00%)
After-Hours: 19:21
Genmab SG&A Expense (Quarterly) : 166.61M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ascendis Pharma A/S | 169.91M |
| Zealand Pharma A/S | 16.29M |
| Bavarian Nordic A/S | 47.93M |
| Evaxion AS | 1.527M |
| Johnson & Johnson | 6.034B |